Application 208531
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS CO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TICAGRELOR | TICAGRELOR | TABLET;ORAL | 90MG | No | No |
| 002 | TICAGRELOR | TICAGRELOR | TABLET;ORAL | 60MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208531-001 | TICAGRELOR | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | ||
| A208531-002 | TICAGRELOR | TICAGRELOR | 60MG | TABLET / ORAL | 2025-10-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208531-001 | TICAGRELOR | 90MG | TABLET / ORAL | 2019-01-23 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208531-002 | TICAGRELOR | 60MG | TABLET / ORAL | 2025-10-28 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A208531-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208531-002 | AB | 1 | 31067a03dcf5… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208531-001 | PC | 2025-10-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208531-001 | PC | 2025-10-28 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ticagrelor | TICAGRELOR | Redpharm Drug | 557351f1-47b7-216d-e063-6394a90afb51 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| ticagrelor | TICAGRELOR | ScieGen Pharmaceuticals INC | 40ac26dc-2570-de7e-e063-6294a90ade72 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Teva Pharmaceuticals, Inc. | 1bbdc202-bbe4-4aec-b4e9-1f1feb41d819 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Laurus Labs Limited | 555d4e44-9bb2-474e-9bea-c549e3261dbb | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| TICAGRELOR | TICAGRELOR | Aphena Pharma Solutions - Tennessee, LLC | 5955a5f5-fbc7-8f67-e063-6394a90ada36 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | TICAGRELOR TICAGRELOR |
| Ticagrelor | TICAGRELOR | Hisun Pharmaceuticals USA, Inc. | c4c1ca82-99bd-451a-ad77-7fe28c4ae3e8 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | AiPing Pharmaceutical, Inc | 4ecb82df-fad2-1f6c-e063-6294a90a9d19 | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Golden State Medical Supply, Inc. | 37f1d3d7-030f-180a-e063-6294a90a89da | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Macleods Pharmaceuticals Limited | 32769721-c1dd-4bd3-90aa-a6cab59d3cd6 | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | NorthStar RxLLC | c89c29c9-d2c0-4605-b74f-059e0b104977 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Apotex Corp. | 2c59ea45-6113-6e9e-70b5-3b8c8b3d89b6 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Dr. Reddys Laboratories Inc | 1225fd45-9b56-1671-ee77-cd0c9f2174a5 | 2026-05-30 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| Ticagrelor | TICAGRELOR | Lifestar Pharma LLC | 7efe86fa-5d19-413a-8b15-e51279b62f3f | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| BRILINTA | TICAGRELOR | AstraZeneca Pharmaceuticals LP | f7b3f443-e83d-4bf2-0e96-023448fed9a8 | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | TICAGRELOR |
| BRILINTA | TICAGRELOR | Cardinal Health 107, LLC | 4f9bd52a-99a7-4606-92b4-456a917aabef | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | TICAGRELOR |
| TICAGRELOR | TICAGRELOR | Novadoz Pharmaceuticals LLC | b1c29d47-960f-4fc4-b6ff-399e2c6eec4c | 2026-02-09 | Boxed warning, Warnings, Adverse reactions | TICAGRELOR TICAGRELOR |
| TICAGRELOR | TICAGRELOR | Aphena Pharma Solutions - Tennessee, LLC | 37b2d081-c17a-c126-e063-6394a90a5729 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | TICAGRELOR TICAGRELOR |
| Ticagrelor | TICAGRELOR | Aphena Pharma Solutions - Tennessee, LLC | 41c5d35c-91de-a8a4-e063-6394a90ac5ff | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | Ticagrelor TICAGRELOR |
| ticagrelor | TICAGRELOR | Radha Pharmaceuticals INC | 436d1bef-da01-7d0a-e063-6294a90abd90 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | ticagrelor TICAGRELOR |
| TICAGRELOR | TICAGRELOR | Solco Healthcare U.S., LLC | 5be5ef20-fc9f-4c3b-a482-83ffd8a3ab47 | 2025-11-11 | Boxed warning, Warnings, Adverse reactions | TICAGRELOR TICAGRELOR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69238-1134 | ticagrelor | ticagrelor | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1134 | ticagrelor | ticagrelor | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1134 | ticagrelor | ticagrelor | Amneal Pharmaceuticals NY LLC | ANDA | Current |
| 69238-1134 | Ticagrelor | Ticagrelor | Amneal Pharmaceuticals LLC | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 57716 | ORIG | 2019-02-21 |